Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension

Author(s):  Allen Loyd V Jr

Issue:  Nov/Dec 2019 - Volume 23, Number 6
View All Articles in Issue

Abstract:  A formulation for preparing Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: ursodiol, formulation, ursodeoxycholic acid, secondary biliary acid, gallstones, primary biliary cholangitis, primary biliary cirrhosis, cholelithiasis

Related Categories: EXCIPIENTS, FORMULATIONS, GASTROENTEROLOGY, UROLOGY/URINARY TRACT

Purchase this article for download in electronic PDF format from IJPC at for $75 at:
https://ijpc.com/Abstracts/Abstract.cfm?ABS=4696

Search the entire IJPC archive by keyword, topic, or issue at:
https://ijpc.com/Products